Search research articles
Contact Us
Filters
Showing results (71-80 of 1,570) with videos related to
Page
of 157
Sort By:
Microbes and Infection
|
March 26, 2003
Microbiological exploitation of the chemokine system
Peter J Holst, Mette M Rosenkilde
Expert Opinion on Pharmacotherapy
|
August 8, 2013
Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety
Carolyn F Deacon, Jens J Holst
Acta Endocrinologica
|
December 1, 1981
Heterogeneity of somatostatin like immunoreactivity (SLI) in extracts of porcine, canine and human pancreas
C B Newgard, J J Holst
Expert Opinion on Investigational Drugs
|
December 2, 2009
Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes
Carolyn F Deacon, Jens J Holst
Best Practice & Research. Clinical Endocrinology & Metabolism
|
September 15, 2009
Immunoassays for the incretin hormones GIP and GLP-1
Carolyn F Deacon, Jens J Holst
Agents and Actions
|
April 1, 1989
Differential regulation of membrane receptors sensitive to histamine (H2-type), isoproterenol (beta 2-type) and glucagon-like peptides by the somatostatin analogue Sandostatin in rat gastric glands
C Gespach, A Hansen, J Holst
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1984
Gastrin-releasing peptide: pharmacokinetics and effects on gastro-entero-pancreatic hormones and gastric secretion in normal men
U Knigge, J J Holst, S Knuhtsen, et al.
Maturitas
|
October 1, 1986
Endometrial response in post-menopausal women during treatment with percutaneous 17 beta-oestradiol opposed by oral progesterone
J Holst, S Cajander, B von Schoultz
Gastroenterology
|
May 1, 1976
Inhibition of gastric acid secretion in man by exogenous and endogenous pancreatic glucagon
J Christiansen, J J Holst, E Kalaja
Peptides
|
July 1, 1987
Extraction of neurotensin-like immunoreactivities from porcine ileal mucosa
Y Yamashita, J Holst Pedersen, F Stadil
Page
of 157
Search research articles
Search
Showing results (71-80 of 1,570) with videos related to
Sort By:
Page
of 157
Microbes and Infection
|
March 26, 2003
Microbiological exploitation of the chemokine system
Peter J Holst, Mette M Rosenkilde
Expert Opinion on Pharmacotherapy
|
August 8, 2013
Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety
Carolyn F Deacon, Jens J Holst
Acta Endocrinologica
|
December 1, 1981
Heterogeneity of somatostatin like immunoreactivity (SLI) in extracts of porcine, canine and human pancreas
C B Newgard, J J Holst
Expert Opinion on Investigational Drugs
|
December 2, 2009
Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes
Carolyn F Deacon, Jens J Holst
Best Practice & Research. Clinical Endocrinology & Metabolism
|
September 15, 2009
Immunoassays for the incretin hormones GIP and GLP-1
Carolyn F Deacon, Jens J Holst
Agents and Actions
|
April 1, 1989
Differential regulation of membrane receptors sensitive to histamine (H2-type), isoproterenol (beta 2-type) and glucagon-like peptides by the somatostatin analogue Sandostatin in rat gastric glands
C Gespach, A Hansen, J Holst
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1984
Gastrin-releasing peptide: pharmacokinetics and effects on gastro-entero-pancreatic hormones and gastric secretion in normal men
U Knigge, J J Holst, S Knuhtsen, et al.
Maturitas
|
October 1, 1986
Endometrial response in post-menopausal women during treatment with percutaneous 17 beta-oestradiol opposed by oral progesterone
J Holst, S Cajander, B von Schoultz
Gastroenterology
|
May 1, 1976
Inhibition of gastric acid secretion in man by exogenous and endogenous pancreatic glucagon
J Christiansen, J J Holst, E Kalaja
Peptides
|
July 1, 1987
Extraction of neurotensin-like immunoreactivities from porcine ileal mucosa
Y Yamashita, J Holst Pedersen, F Stadil
Page
of 157